Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Metastatic thyroid carcinoma with hyperthyroidism (author's transl)]

M Daumont, R Mornex, G Pousset

Annales D'Endocrinologie

|March 1, 1977

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Same author

Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study.

Bone marrow transplantation·2016

Same author

Acute Leukemia with a Translocation T(4;11)(q21;q23): a Distinct Clinicopathological Entity: Report of a Case with Cytogenetic Clonal Evolution and Review of 146 Cases of the Literature.

Leukemia & lymphoma·2016

Same author

Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study.

Bone marrow transplantation·2015

Same author

GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-κB-dependent induction of HIF-1α.

Leukemia·2014

Same author

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Radioiodine therapy effectively treated thyroid carcinoma metastasis in bones and liver. High-dose radioactive iodine (131I) administration led to clinical regression of metastases and hypothyroidism.

Area of Science:

Endocrinology
Oncology
Nuclear Medicine

Background:

Thyroid carcinoma can metastasize to distant organs like bone and liver.
Radioiodine uptake in metastatic lesions indicates functional thyroid tissue, a target for therapy.
Thyrotoxicosis can occur in patients with metastatic thyroid cancer.

Observation:

A patient with thyroid carcinoma developed widespread bone and liver metastases with high radioiodine uptake.
The patient presented with thyrotoxicosis, low iodine uptake in residual thyroid tissue, and suppressed TSH.
Administration of 240 millicuries of radioactive iodine (131I) was given.

Findings:

The 131I treatment resulted in hypothyroidism.
Clinical regression of liver metastases was observed.

Related Experiment Videos

Extra-cervical iodine uptake disappeared post-treatment.

Implications:

High-dose radioiodine therapy can be effective for managing extensive thyroid cancer metastases.
This approach can lead to remission of metastatic disease, albeit with induced hypothyroidism.
Understanding iodine uptake patterns is crucial for effective treatment strategies in advanced thyroid carcinoma.